CHA Medical Center-backed Solidus Investment Company has returned for a $30m series B round in Orum Therapeutics, which is targeting cancer and rare diseases.

Illumina Ventures and Section 32 co-led the non-invasive prenatal test maker's $17.1m round, which featured Alexandria Real Estate Equities.

University of Chicago immuno-oncology spinout Pyxis Oncology has been backed by corporate investment vehicle Leaps by Bayer in its first funding round.

Florida State spinout Trefoil Therapeutics added funding from investors including subsidiaries of Aju Corporation and Access Biotechnology to bring its total to $33.2m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Boehringer Ingelheim will pay a total of up to $365m to acquire its venture fund's portfolio company Amal Therapeutics, an immunotherapy spinout of University of Geneva.

Boehringer Ingelheim will pay a total of up to $365m to acquire its venture fund's portfolio company Amal Therapeutics, an immunotherapy spinout of University of Geneva.

Orchestra BioMed has confirmed Temuro’s participation in a $34m series B1 round, a month after the corporate entered into a strategic agreement that had it invest $5m of equity.

The series C for Utah-founded drug discovery platform creator Recursion included capital from University of Minnesota and Texas Tech University System.

Entrepreneurs Fund’s EF Investments and Bayern Kapital contributed to a round that increased Würzburg-founded traumatic brain injury drug developer Vasopharm’s total to above $57.8m.